EUVIMEDEUVIMED entdecken
Übersichtsarbeit

p16 INK4a /Ki67 Dual-Staining Immunocytochemistry to Refer Women Infected by High-Risk Human Papillomavirus for Colposcopy

Magnus von Knebel Doeberitz

Acta Cytologica · 2025

DOI: 10.1159/000542504 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Acta Cytologica, 2025. Verfasst von Magnus von Knebel Doeberitz. Beteiligte Einrichtung: Department of Applied Tumor Biology, Institute of Pathology, University Hospital Heidelberg, Heidelberg, Germany. Hauptthemen laut MEDLINE: Cyclin-Dependent Kinase Inhibitor p16, Papillomavirus Infections, Colposcopy, Uterine Cervical Neoplasms. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 60 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background: Cervical cancer is still a significant global health issue, especially in low- and middle-income countries. Human papillomavirus (HPV) infection is known to be the primary etiological factor in the development of cervical cancer. The identification of high-risk HPV (HR-HPV) infections in cervical cancer screening is becoming crucial for early detection and management of cervical pre-neoplasia. However, HPV testing requires triage markers since HR-HPV infections are widespread in the target population, of which only a small fraction requires detailed clinical workup by colposcopy. Summary: p16INK4a is a tumor suppressor protein that has emerged as a promising surrogate marker for HPV infection. In combination with a proliferation marker Ki67 in one diagnostic test kit referred to as CINtecPlus® or dual stain (DS), it revealed excellent sensitivity and specificity profiles to detect clinically relevant CIN2+ lesions among HPV-infected women in large screening cohorts. Key Message: This review examines the role of the cytology CINtecPlus® test (DS test) as a triage marker to identify patients with CIN2+ lesions among HPV+ tested women and summarizes the most recent recommendations for its clinical use.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cyclin-Dependent Kinase Inhibitor p16Papillomavirus InfectionsColposcopyUterine Cervical NeoplasmsKi-67 AntigenImmunohistochemistryUterine Cervical DysplasiaBiomarkers, TumorHumansFemaleEarly Detection of CancerPredictive Value of TestsPapillomaviridaeTriageHuman Papillomavirus Viruses

Stichwörter der Autor:innen

Cervical cancerHigh-risk human papillomavirus infectionImmunocytochemistryMolecular markerScreening

Substanzen

Cyclin-Dependent Kinase Inhibitor p16Ki-67 AntigenCDKN2A protein, humanBiomarkers, TumorMKI67 protein, human

Autor:innen und Institutionen

  • Department of Applied Tumor Biology, Institute of Pathology, University Hospital Heidelberg, Heidelberg, Germany.

Zitieren

APA

von Knebel Doeberitz, M. (2025). p16 INK4a /Ki67 Dual-Staining Immunocytochemistry to Refer Women Infected by High-Risk Human Papillomavirus for Colposcopy. Acta Cytologica. https://doi.org/10.1159/000542504

Vancouver

von Knebel Doeberitz M. p16 INK4a /Ki67 Dual-Staining Immunocytochemistry to Refer Women Infected by High-Risk Human Papillomavirus for Colposcopy. Acta Cytologica. 2025. doi:10.1159/000542504

BibTeX
@article{vonKnebelDoeberitz2025,
  author = {von Knebel Doeberitz, Magnus},
  title = {p16 INK4a /Ki67 Dual-Staining Immunocytochemistry to Refer Women Infected by High-Risk Human Papillomavirus for Colposcopy},
  journal = {Acta Cytologica},
  year = {2025},
  doi = {10.1159/000542504}
}
Kostenlos starten →